When researchers at the University of Michigan Rogel Cancer Center first identified a new subtype of aggressive prostate ...

A combination of two types of therapeutic agents selectively killed breast cancer cells in a clinical trial, offering hope ...

When researchers at the University of Michigan Rogel Cancer Center first identified a new subtype of aggressive prostate ...

University of Michigan researchers have made significant strides in understanding and treating a new, aggressive subtype of ...

Researchers at the University of Michigan Rogel Cancer Center have recently uncovered a novel subtype of aggressive prostate ...

That is notable as most protein degraders are too large to be absorbed orally, which has limited their potential in drug ...

决定依据《国家自然科学基金项目科研不端行为调查处理办法》第五十条第一项、第四项和第四十四条第四项，取消全成国家自然科学基金项目评审专家资格3年（2024年4月9日至2027年4月8日），取消全成国家自然科学基金项目申请和参与申请资格2年（2024年4月9日至2026年4月8日），给予全成通报批评。

When researchers at the University of Michigan Rogel Cancer Center first identified a new subtype of aggressive prostate cancer, they knew they needed to understand how this genetic alteration was ...

Northwestern Medicine scientists have discovered a new mechanism that controls a specialized group of T-cells, known as ...

As Roche comes under competitive pressure on its breast cancer business, the Swiss company hopes a new drug will add a ...

A study led by researchers of the Institute of Biomedicine of the University of Barcelona (IBUB) has developed a new ...

This useful study reports that the exogenous expression of the microRNA miR-195 can partially compensate in early B cell development for the loss of EBF1, one of the key transcription factors in B ...